CLINICAL_TRIALS trial_result · 2013-11-11

Clinical Trial Update: Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety [Phase 3]

Phase 3 trial completed evaluating Yohimbine as an adjunct to Cognitive Behavioral Therapy for Social Anxiety Disorder. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Southern Methodist University | Conditions: Social Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-11-11